Panagiotis Douvaras

This inventor holds 4 USPTO granted patents and 4 published patent applications and 1 EPO patent. Top assignee: New York Stem Cell Foundation, Inc.. Active years: 2019-2023.

USPTO Granted Patents = 4 (Patent Applications = 4)

% Patents Active = 100.0

EPO Patents = 1 (Patent Applications = 3)

Average Co-Inventor Count = 2.3

ph-index = 2

Forward Citations = 8(Granted Patents)

Company Filing History:

4 out of 25

New York Stem Cell Foundation, Inc.

patents

Years Active: 2019-2023

Loading Chart...

4 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11814648 - Functional oligodendrocytes derived from pluripotent stem cells and methods of making and using the same (2023-11-14),

2. 11149250 - Microglia derived from pluripotent stem cells and methods of making and using the same (2021-10-19),

3. 10676716 - Functional oligodendrocytes derived from pluripotent stem cells and methods of making and using the same (2020-06-09),

4. 10301592 - Functional oligodendrocytes derived from pluripotent stem cells and methods of making and using the same (2019-05-28),

Title: Panagiotis Douvaras: Pioneering Inventor from New York

Introduction: Panagiotis Douvaras is a renowned inventor based in New York, NY, known for his groundbreaking innovations in various fields.

Latest Patents: Panagiotis Douvaras holds several patents in the areas of renewable energy technologies, medical devices, and artificial intelligence systems.

Career Highlights: With a career spanning over two decades, Panagiotis Douvaras has worked with leading research institutions and companies to develop cutting-edge solutions that have had a significant impact on society.

Collaborations: Throughout his career, Panagiotis Douvaras has collaborated with top scientists, engineers, and inventors from around the world, fostering a culture of innovation and excellence.

Conclusion: Panagiotis Douvaras continues to push the boundaries of technology and science, leaving a lasting legacy in the world of inventions and innovations.

Profile summary based on public USPTO records.